Paper36313348
Integrated network pharmacology and serum metabolomics approach deciphers the anti-colon cancer mechanisms of Huangqi Guizhi Wuwu Decoction.
Pan B and 9 others. Front Pharmacol, 2022. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Integrated network pharmacology and serum metabolomics approach deciphers the anti-colon cancer mechanisms of Huangqi Guizhi Wuwu Decoction. Papers, record 36313348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36313348
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Integrated network pharmacology and serum metabolomics approach deciphers the anti-colon cancer mechanisms of Huangqi Guizhi Wuwu Decoction.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26677144 | Cinnamaldehyde affects the biological behavior of human colorectal cancer cells and induces apoptosis via inhibition of the PI3K/Akt signaling pathway. | Oncol Rep | 2016 | https://conductscience.org/library/papers/26677144 | PubMed |
| 2 | 23701745 | Cinnamic acid induces apoptotic cell death and cytoskeleton disruption in human melanoma cells. | J Exp Clin Cancer Res | 2013 | https://conductscience.org/library/papers/23701745 | PubMed |
| 3 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 4 | 17687303 | New uses for old drugs. | Nature | 2007 | https://conductscience.org/library/papers/17687303 | PubMed |
| 5 | 34931768 | Cancer metabolism and dietary interventions. | Cancer Biol Med | 2022 | https://conductscience.org/library/papers/34931768 | PubMed |
| 6 | 34612013 | Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas. | Cancer Med | 2021 | https://conductscience.org/library/papers/34612013 | PubMed |
| 7 | 29710520 | Astragaloside IV inhibits cell proliferation of colorectal cancer cell lines through down-regulation of B7-H3. | Biomed Pharmacother | 2018 | https://conductscience.org/library/papers/29710520 | PubMed |
| 8 | 18930523 | Traditional Chinese medicine. | Lancet | 2008 | https://conductscience.org/library/papers/18930523 | PubMed |
| 9 | 33200026 | Chinese herbal compounds against SARS-CoV-2: Puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor. | Comput Struct Biotechnol J | 2020 | https://conductscience.org/library/papers/33200026 | PubMed |
| 10 | 29621222 | Metabolomics activity screening for identifying metabolites that modulate phenotype. | Nat Biotechnol | 2018 | https://conductscience.org/library/papers/29621222 | PubMed |
| 11 | 29190639 | Induction of colon and cervical cancer cell death by cinnamic acid derivatives is mediated through the inhibition of Histone Deacetylases (HDAC). | PLoS One | 2017 | https://conductscience.org/library/papers/29190639 | PubMed |
| 12 | 26444366 | Beauty. | Nature | 2015 | https://conductscience.org/library/papers/26444366 | PubMed |
| 13 | 32481364 | Study on efficacy and safety of Huangqi Guizhi Wuwu decoction treatment for oxaliplatin induced peripheral neurotoxicity: A protocol for a randomized, controlled, double-blind, multicenter trial. | Medicine (Baltimore) | 2020 | https://conductscience.org/library/papers/32481364 | PubMed |
| 14 | 35678522 | Cinnamaldehyde decreases the invasion and u-PA expression of osteosarcoma by down-regulating the FAK signalling pathway. | Food Funct | 2022 | https://conductscience.org/library/papers/35678522 | PubMed |
| 15 | 27144067 | Colorectal cancer carcinogenesis: a review of mechanisms. | Cancer Biol Med | 2016 | https://conductscience.org/library/papers/27144067 | PubMed |
| 16 | 19998273 | Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. | Cancer | 2010 | https://conductscience.org/library/papers/19998273 | PubMed |
| 17 | 30810776 | Function, essentiality, and expression of cytochrome P450 enzymes and their cognate redox partners in Mycobacterium tuberculosis: are they drug targets? | Appl Microbiol Biotechnol | 2019 | https://conductscience.org/library/papers/30810776 | PubMed |
| 18 | 30896841 | Astragaloside IV inhibits the invasion and metastasis of SiHa cervical cancer cells via the TGF‑β1‑mediated PI3K and MAPK pathways. | Oncol Rep | 2019 | https://conductscience.org/library/papers/30896841 | PubMed |
| 19 | 30034946 | Add-On therapy with Chinese herb medicine Bo-Er-Ning capsule (BENC) improves outcomes of gastric cancer patients: a randomized clinical trial followed with bioinformatics-assisted mechanism study. | Am J Cancer Res | 2018 | https://conductscience.org/library/papers/30034946 | PubMed |
| 20 | 32694690 | Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities. | Nat Metab | 2020 | https://conductscience.org/library/papers/32694690 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42741754 | Herbal Formula AC591 Protects Against Cisplatin-Induced Hearing Loss by Inhibiting p53-Mediated Ferroptosis. | Smart Med | 2026 | https://conductscience.org/library/papers/42741754 | PubMed |
| 40855327 | Multi-omics analysis reveals ACOT1 as the key target of piperine in Piper Longum-mediated gastric cancer treatment. | Chin Med | 2025 | https://conductscience.org/library/papers/40855327 | PubMed |
| 39565454 | Exploring the potential anti-diabetic peripheral neuropathy mechanisms of Huangqi Guizhi Wuwu Decoction by network pharmacology and molecular docking. | Metab Brain Dis | 2024 | https://conductscience.org/library/papers/39565454 | PubMed |
| 39468922 | From complexity to clarity: development of CHM-FIEFP for predicting effective components in Chinese herbal formulas by using big data. | Cancer Biol Med | 2024 | https://conductscience.org/library/papers/39468922 | PubMed |
| 37679804 | Huangqi Guizhi Wuwu decoction alleviates oxaliplatin-induced peripheral neuropathy via the gut-peripheral nerve axis. | Chin Med | 2023 | https://conductscience.org/library/papers/37679804 | PubMed |
| 37222828 | UPLC-Q-TOF/MS-Based Serum Metabolomics Reveals Potential Anti-tumor Mechanism of Banxia Xiexin Decoction in Colorectal Cancer Mice. | Chin J Integr Med | 2024 | https://conductscience.org/library/papers/37222828 | PubMed |
| 37081969 | Metabolomics-based discovery of XHP as a CYP3A4 inhibitor against pancreatic cancer. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37081969 | PubMed |
| 36624435 | Exploration of the mechanism by which Huangqi Guizhi Wuwu decoction inhibits Lps-induced inflammation by regulating macrophage polarization based on network pharmacology. | BMC Complement Med Ther | 2023 | https://conductscience.org/library/papers/36624435 | PubMed |
Genes21
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36313348
GET https://conductscience.org/api/papers/v1/36313348/references?page=2